Error loading player: No playable sources found

AM23-TU-05-O

AM23-TU-05-O: Use of Apheresis Modalities for the Management of Solid Organ Transplant Rejection (Enduring)

Credits
1.5 General Continuing Education (GEN) | 1.5 Florida Lab Personnel (FLP) | 1.5 California Nurse (CN) | 1.5 California Lab Personnel (CLP) | 1.5 Physician (PHY)
$3000
Standard Price
Members save $5

Therapeutic apheresis modalities, including therapeutic plasma exchange and extracorporeal photopheresis (ECP), are increasingly being utilized as part of the multidisciplinary care of solid organ transplant recipients. This session will compare and contrast different treatment regimens currently employed for preventing and treating solid organ transplant rejection. We will review the indications for initiating treatment with apheresis and the impact on patient outcomes. We will review the pathophysiology of organ rejection and more recent data on using ECP to induce organ tolerance. We will highlight ECP's role in managing chronic lung allograft rejection.

Learning Objectives

  • Describe the pathophysiology of organ rejection, therapeutic options, and proposed mechanisms of action of extracorporeal photopheresis and therapeutic plasma exchange
  • Contrast different treatment protocols using therapeutic plasma exchange and extracorporeal photopheresis in the management solid organ transplant rejection
  • Compare outcomes of apheresis-based regimens in the treatment of organ rejection
  • Examine the data supporting the ability of extracorporeal photopheresis to induce organ tolerance
  • Recognize the emerging role of extracorporeal photopheresis in the treatment of chronic lung allograft rejection (CLAD)

Moderator

Speaker Image for Jennifer Webb
Jennifer Webb, MD, MSCE
Associate Professor of Pediatrics, Director of Therapeutic Apheresis, Children's National Hospital

Speakers

Speaker Image for Grace Lee
Assistant Professor, Duke University Medical Center
Speaker Image for Joseph Leventhal
Joseph Leventhal, MD, PhD, FACS
Fowler McCormick Professor of Surgery; Deputy Director of the Comprehensive Transplant Center, Northwestern Medical Group
Speaker Image for Michael Tsifansky
Medical Director Advanced Lung Disease and Transplant Program, Children's National Hospital

Tracks

Related Products

Thumbnail for AM24-MN-17-O: Making Learning Stick – Effective Training for Blood and Biotherapies Professionals (Enduring)
AM24-MN-17-O: Making Learning Stick – Effective Training for Blood and Biotherapies Professionals (Enduring)
The future of the blood and biotherapies fields depends on our ability to prepare a new generation of leaders and skilled professionals to continue advancing the field…
Thumbnail for AM24-MN-43-O: Trans, Non-binary, and Gender-Diverse Peoples: How You Can Make a Difference for Donors, Patients, and Communities (Enduring)
AM24-MN-43-O: Trans, Non-binary, and Gender-Diverse Peoples: How You Can Make a Difference for Donors, Patients, and Communities (Enduring)
Many blood operators around the world are implementing individualized donor assessments that welcome more trans, non-binary, and gender-diverse people to donate…
Thumbnail for AM24-MN-25-O: Pediatric Transfusion Medicine: A Coming of Age Journey (presented by Cassandra Josephson, Emily Cooley Memorial Award recipient) (Enduring)
AM24-MN-25-O: Pediatric Transfusion Medicine: A Coming of Age Journey (presented by Cassandra Josephson, Emily Cooley Memorial Award recipient) (Enduring)
Come join the party as we celebrate the coming of age of pediatric transfusion medicine (PTM). This session will provide a montage of the superheroes and their influence and impact on mentees and PTM over the past 3-4 decades…